REGENXBIO Inc. (RGNX): Price and Financial Metrics
REGENXBIO Inc. (RGNX)
Today's Latest Price: $48.38 USD
0.72 (-1.47%)
Updated Jan 17 2:36pm
Add RGNX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
RGNX Stock Summary
- With a price/sales ratio of 26.87, REGENXBIO Inc has a higher such ratio than 95.4% of stocks in our set.
- Equity multiplier, or assets relative to shareholders' equity, comes in at 1.07 for REGENXBIO Inc; that's greater than it is for merely 7.21% of US stocks.
- Revenue growth over the past 12 months for REGENXBIO Inc comes in at -64.26%, a number that bests just 2.34% of the US stocks we're tracking.
- Stocks that are quantitatively similar to RGNX, based on their financial statements, market capitalization, and price volatility, are CLDX, APTX, AGTC, IMGN, and SURF.
- RGNX's SEC filings can be seen here. And to visit REGENXBIO Inc's official web site, go to www.regenxbio.com.
RGNX Daily Price Range
RGNX 52-Week Price Range
RGNX Stock Price Chart More Charts
RGNX Price/Volume Stats
| Current price | $48.38 | 52-week high | $63.21 |
| Prev. close | $49.10 | 52-week low | $30.38 |
| Day low | $48.36 | Volume | 287,132 |
| Day high | $50.09 | Avg. volume | 488,907 |
| 50-day MA | $41.38 | Dividend yield | N/A |
| 200-day MA | $43.08 | Market Cap | 1.78B |
REGENXBIO Inc. (RGNX) Company Bio
REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno-associated virus (AAV) gene therapy. The company was founded in 2009 and is based in Rockville, Maryland.
Loading social stream, please wait...